Literature DB >> 15964567

The dual role of prostaglandin E(2) in excitotoxicity and preconditioning-induced neuroprotection.

Tania F Gendron1, Eric Brunette, Joseph S Tauskela, Paul Morley.   

Abstract

Cyclooxygenase-2 is harmful in models of cerebral ischemia yet plays a protective role in preconditioning-induced ischemic tolerance in the heart. This study examined the mechanisms underlying cyclooxygenase-2-mediated neurotoxicity and preconditioning-induced neuroprotection in an in vitro model of cerebral ischemia. Inhibition of cyclooxygenase-2 protects cortical neuronal cultures from death induced by oxygen-glucose deprivation and reduces oxygen-glucose deprivation-induced increases in intracellular Ca(2+) ([Ca(2+)](i)). In the present study, we determined if prostaglandin E(2) (PGE(2)) is responsible for this cyclooxygenase-2-mediated effect. Rat cortical cultures expressed mRNA for the prostanoid EP(1)-EP(4) receptors. PGE(2) reversed the attenuation in [Ca(2+)](i) and the protection offered by cyclooxygenase-2 inhibition during oxygen-glucose deprivation. These effects likely occur via activation of the prostanoid EP(1) receptor since blocking this receptor during oxygen-glucose deprivation reduced [Ca(2+)](i) and neurotoxicity. Next, we considered if the moderate activation of this pathway, by preconditioning cultures with sub-lethal oxygen-glucose deprivation, influenced the development of tolerance to an otherwise lethal oxygen-glucose deprivation insult, 48 h later. Inhibition of cyclooxygenase-2 during oxygen-glucose deprivation-preconditioning abolished preconditioning-induced protection. Furthermore, cultures were rendered tolerant to oxygen-glucose deprivation by the transient exposure to exogenous PGE(2) 24 h prior to the insult, indicating that this product of the cyclooxygenase-2 pathway is sufficient to induce ischemic tolerance. This study shows that cyclooxygenase-2 and PGE(2) are involved in both oxygen-glucose deprivation-induced neurotoxicity and preconditioning-induced neuroprotection. While neurotoxic in the context of lethal oxygen-glucose deprivation, the moderate activation of this signalling pathway confers ischemic tolerance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964567     DOI: 10.1016/j.ejphar.2005.05.031

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  18 in total

1.  CRE-mediated transcription and COX-2 expression in the pilocarpine model of status epilepticus.

Authors:  Boyoung Lee; Heather Dziema; Kyu Hyun Lee; Yun-Sik Choi; Karl Obrietan
Journal:  Neurobiol Dis       Date:  2006-10-09       Impact factor: 5.996

2.  Ischemic preconditioning via epsilon protein kinase C activation requires cyclooxygenase-2 activation in vitro.

Authors:  E Kim; A P Raval; R A Defazio; M A Perez-Pinzon
Journal:  Neuroscience       Date:  2007-02-20       Impact factor: 3.590

3.  Ischemic preconditioning mediates cyclooxygenase-2 expression via nuclear factor-kappa B activation in mixed cortical neuronal cultures.

Authors:  Eun Joo Kim; Ami P Raval; Nina Hirsch; Miguel A Perez-Pinzon
Journal:  Transl Stroke Res       Date:  2010-01-26       Impact factor: 6.829

4.  Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation.

Authors:  Abdullah Shafique Ahmad; Yun Tai Yun; Muzamil Ahmad; Takayuki Maruyama; Sylvain Doré
Journal:  Neurotox Res       Date:  2008-12       Impact factor: 3.911

5.  Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death.

Authors:  Noel G Carlson; Monica A Rojas; Jonathan W Redd; Philip Tang; Blair Wood; Kenneth E Hill; John W Rose
Journal:  J Neuroinflammation       Date:  2010-04-13       Impact factor: 8.322

6.  Involvement of PGE2 and PGDH but not COX-2 in thrombin-induced cortical neuron apoptosis.

Authors:  Lakshmi Thirumangalakudi; Haripriya Vittal Rao; Paula Grammas
Journal:  Neurosci Lett       Date:  2009-01-21       Impact factor: 3.046

7.  Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia.

Authors:  Tatsurou Yagami
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

8.  Selective increase of neuronal cyclooxygenase-2 (COX-2) expression in vulnerable brain regions of rats with experimental Wernicke's encephalopathy: effect of nimesulide.

Authors:  Baoying Gu; Paul Desjardins; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2008-05-15       Impact factor: 3.584

9.  Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia.

Authors:  Sofiyan Saleem; Yun Tai Kim; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  J Neuroimmunol       Date:  2009-02-08       Impact factor: 3.478

10.  Elevated microsomal prostaglandin-E synthase-1 in Alzheimer's disease.

Authors:  Uzma A Chaudhry; Hean Zhuang; Barbara J Crain; Sylvain Doré
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.